October 10, 2023NeurologyOpen Access

Using ¹⁸ F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease

View Full Paper

Ask AI

Bookmark

Abstract

This study provides Class IV evidence that VMAT2 PET can detect patients with Parkinson disease and quantify progression over a 2-year window.

No takes yet. Share an insight, caveat, or question.

Beauchamp et al. (2023) studied this question.

View Full Paper

Ask AI

Bookmark

This study provides Class IV evidence that VMAT2 PET can detect patients with Parkinson disease and quantify progression over a 2-year window.